These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23199039)

  • 41. Diabetes mellitus-associated vascular impairment: novel circulating biomarkers and therapeutic approaches.
    Tousoulis D; Papageorgiou N; Androulakis E; Siasos G; Latsios G; Tentolouris K; Stefanadis C
    J Am Coll Cardiol; 2013 Aug; 62(8):667-76. PubMed ID: 23948511
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Plasminogen activator inhibitor (PAI-1) and markers of endothelial dysfunction in patients with diabetes mellitus].
    Galajda P; Martinka E; Baláz D; Stasko J; Kerný J; Planková E; Mokán M; Kubisz P
    Vnitr Lek; 1997 Nov; 43(11):744-7. PubMed ID: 9650506
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effects of exercise stress testing on soluble E-selectin, von Willebrand factor, and circulating endothelial cells as indices of endothelial damage/dysfunction.
    Boos CJ; Balakrishnan B; Lip GY
    Ann Med; 2008; 40(1):66-73. PubMed ID: 17934907
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic role of plasma von Willebrand factor and soluble E-selectin levels for future cardiovascular events in a 'real-world' community cohort of patients with atrial fibrillation.
    Krishnamoorthy S; Khoo CW; Lim HS; Lane DA; Pignatelli P; Basili S; Violi F; Lip GY
    Eur J Clin Invest; 2013 Oct; 43(10):1032-8. PubMed ID: 23961715
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease.
    Tsakiris DA; Tschöpl M; Jäger K; Haefeli WE; Wolf F; Marbet GA
    Atherosclerosis; 1999 Jan; 142(1):193-200. PubMed ID: 9920521
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlation between soluble markers of endothelial dysfunction in patients with renal failure.
    Jacobson SH; Egberg N; Hylander B; Lundahl J
    Am J Nephrol; 2002; 22(1):42-7. PubMed ID: 11919402
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.
    Freestone B; Chong AY; Nuttall S; Lip GY
    Thromb Res; 2008; 122(1):85-90. PubMed ID: 17996280
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis.
    De Caterina R; Basta G; Lazzerini G; Dell'Omo G; Petrucci R; Morale M; Carmassi F; Pedrinelli R
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2646-54. PubMed ID: 9409238
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endothelial cell injury markers in chronic renal failure on conservative treatment and continuous ambulatory peritoneal dialysis.
    Małyszko J; Małyszko JS; Myśliwiec M
    Kidney Blood Press Res; 2004; 27(2):71-7. PubMed ID: 14691349
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aortic endothelial cell von Willebrand factor content, and circulating plasminogen activator inhibitor-1 are increased, but expression of endothelial leukocyte adhesion molecules is unchanged in insulin-dependent diabetic BB rats.
    Ribau JC; Samis JA; Senis YA; Maurice DH; Giles AR; DeReske M; Absher PM; Hatton MW; Richardson M
    Atherosclerosis; 2000 Apr; 149(2):331-42. PubMed ID: 10729383
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endothelial function and biochemical vascular markers in first-degree relatives of type 2 diabetic patients: the effect of exercise training.
    Ostergård T; Nyholm B; Hansen TK; Rasmussen LM; Ingerslev J; Sørensen KE; Bøtker HE; Saltin B; Schmitz O
    Metabolism; 2006 Nov; 55(11):1508-15. PubMed ID: 17046554
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endothelial Activation Markers as Disease Activity and Damage Measures in Juvenile Dermatomyositis.
    Kishi T; Chipman J; Evereklian M; Nghiem K; Stetler-Stevenson M; Rick ME; Centola M; Miller FW; Rider LG
    J Rheumatol; 2020 Jul; 47(7):1011-1018. PubMed ID: 31371656
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease.
    Kamiński TW; Pawlak K; Karbowska M; Myśliwiec M; Pawlak D
    BMC Nephrol; 2017 Jan; 18(1):35. PubMed ID: 28122514
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Soluble endothelial cell molecules and circulating endothelial cells in patients with venous thromboembolism.
    Torres C; Matos R; Morais S; Campos M; Lima M
    Blood Coagul Fibrinolysis; 2017 Dec; 28(8):589-595. PubMed ID: 28661913
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endothelial cell activation in cutaneous vasculitis.
    Jurd KM; Stephens CJ; Black MM; Hunt BJ
    Clin Exp Dermatol; 1996 Jan; 21(1):28-32. PubMed ID: 8689765
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Circulating endothelial cells and progenitors as prognostic factors during autoimmune thrombotic thrombocytopenic purpura: results of a prospective multicenter French study.
    Widemann A; Pasero C; Arnaud L; Poullin P; Loundou AD; Choukroun G; Sanderson F; Lacroix R; Sabatier F; Coppo P; Dignat-George F; Kaplanski G;
    J Thromb Haemost; 2014 Oct; 12(10):1601-9. PubMed ID: 25088020
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Varughese GI; Patel JV; Tomson J; Blann AD; Hughes EA; Lip GY
    J Intern Med; 2007 Apr; 261(4):384-91. PubMed ID: 17391113
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endothelial Permeability and Hemostasis in Septic Shock: Results From the ProCESS Trial.
    Hou PC; Filbin MR; Wang H; Ngo L; Huang DT; Aird WC; Yealy DM; Angus DC; Kellum JA; Shapiro NI;
    Chest; 2017 Jul; 152(1):22-31. PubMed ID: 28109962
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.
    Chong AY; Freestone B; Patel J; Lim HS; Hughes E; Blann AD; Lip GY
    Am J Cardiol; 2006 Mar; 97(5):671-5. PubMed ID: 16490435
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Circulating and progenitor endothelial cells are abnormal in patients with different types of von Willebrand disease and correlate with markers of angiogenesis.
    Gritti G; Cortelezzi A; Bucciarelli P; Rezzonico F; Lonati S; La Marca S; Silvestris I; Federici AB
    Am J Hematol; 2011 Aug; 86(8):650-6. PubMed ID: 21630316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.